Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Wednesday, October 17, 2018
Today, the federal government published the Fall 2018 Unified Agenda, which provides federal agencies the opportunity to share the government’s top regulatory priorities with the American public. For the U.S. Food and Drug Administration (FDA), the Agenda reflects our ongoing commitment to protecting and promoting the public health through science-based decision-making that informs new regulations that advance the public health and promote innovative, efficient oversight of our key areas of influence.
At the beginning of the year, we unveiled FDA’s 2018 Strategic Policy Roadmap. This plan was the product of a close collaboration among the Agency’s centers. Our Strategic Roadmap encompasses four key priorities the Agency is pursuing to advance our public health mission:
1.Reducing the burden of addiction crises that are threatening American families;
2.Leveraging innovation and competition to improve health care, broaden access, and advance public health goals;
3.Empowering consumers to make better and more informed decisions about their diets and health and expand the opportunities to use nutrition to reduce morbidity and mortality from disease; and,
4.Strengthening FDA’s scientific workforce and its tools for efficient risk management.
The Fall 2018 Unified Agenda reflects our continued commitment to these priorities as well as other new steps to enable us to advance these and some additional goals.